Liu, Jessica C.
Vatti, Thanvi
Seth, Kanika
Valentim, Carolina C. S.
Rachitskaya, Aleksandra V.
Singh, Rishi P. http://orcid.org/0000-0001-5859-8162
Article History
Received: 25 July 2022
Revised: 13 January 2023
Accepted: 2 March 2023
First Online: 22 March 2023
Competing interests
: RPS reports personal fees from Genentech/Roche, Alcon/Novartis, Zeiss, Bausch + Lomb, Regeneron Pharmaceuticals, Inc, Gyroscope, Asceplix and Apellis. AR reports personal fees from Alcon, Allergan, Regeneron, Samsara and Zeiss as well as research and personal fees from Genentech and Novartis.